X. Jin

发表

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.

A. Trkola, J. Moore, D. Ho, 1999, The Journal of clinical investigation.

Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

M A Nowak, M. Nowak, D. Ho, 1998, Science.

Simulation and Prediction of the Adaptive Immune Response to Inﬂuenza A Virus Infection (cid:1)

A. Perelson, X. Jin, T. Mosmann, 2009 .

Safety and Immunogenicity of ALVAC vCP1452 and Recombinant gp160 in Newly Human Immunodeﬁciency Virus Type 1-Infected Patients Treated with Prolonged Highly Active Antiretroviral Therapy

D. Ho, J. Binley, X. Jin, 2002 .

Prospects for NK-based immunotherapy of chronic HBV infection

X. Jin, Jiacheng Bi, 2022, Frontiers in Immunology.

Subunit vaccines for Acinetobacter baumannii

X. Jin, Ganzhu Feng, Ning Yang, 2023, Frontiers in Immunology.

Application of metagenomic next-generation sequencing in the diagnosis of urinary tract infection in patients undergoing cutaneous ureterostomy

X. Jin, Rong Huang, Liping Tang, 2023, Frontiers in Cellular and Infection Microbiology.

Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease

X. Jin, Xia Jin, A. Carmichael, 1993, The Journal of experimental medicine.

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy.

D. Ho, X. Jin, L. Zhang, 2000, The Journal of clinical investigation.

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.

J. Moore, D. Ho, J. Binley, 1999, The Journal of infectious diseases.

Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project Investigators.

B. Walker, B. Korber, D. Ho, 1998, The Journal of infectious diseases.

Comparison of restimulation methods to elicit SIV specific cytotoxic T-lymphocytes (CTL) in vitro: Staphylococcal enterotoxin B (SEB) provides a novel method for the quantification of SIV specific CTL precursors.

D. Nixon, X. Jin, S. M. Donahoe, 1999, Immunology letters.

Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL

X. Jin, A. Carmichael, X Jin, 1996, Journal of virology.

High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections.

D. Nixon, X. Jin, S. Bonhoeffer, 2000, The Journal of infectious diseases.

Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

M. Nowak, D. Ho, Y. Cao, 1999, Journal of Virology.

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.

R. Steinman, D. Nixon, X. Jin, 1999, AIDS.

Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm.

D. Nixon, X. Jin, L. Zhang, 2000, AIDS research and human retroviruses.

Progressive loss of IL‐2‐expandable HIV‐1‐specific cytotoxic T lymphocytes during asymptomatic HIV infection

X. Jin, M. Wills, J. Sissons, 1998, European journal of immunology.

Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice

Zhiwei Chen, X. Jin, Linqi Zhang, 2018, The Journal of clinical investigation.

Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy.

D. Ho, Y. Cao, D. Nixon, 1999, Immunology letters.

DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques.

D. Ho, L. Stamatatos, X. Jin, 2001, Immunology letters.

DNA Vaccination with the Human Immunodeficiency Virus Type 1 SF162ΔV2 Envelope Elicits Immune Responses That Offer Partial Protection from Simian/Human Immunodeficiency Virus Infection to CD8+ T-Cell-Depleted Rhesus Macaques

D. Ho, L. Stamatatos, X. Jin, 2001, Journal of Virology.

The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL

X. Jin, M. Weekes, M. Wills, 1996, Journal of virology.

Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1: Report* from a meeting of the WHO-UNAIDS Vaccine Advisory Committee** Geneva, 21–23 February 2000

Guido Ferrari, N. Nathanson, Donald S. Burke, 2001, AIDS.

Progressive loss of IL‐2‐expandable HIV‐1‐specific cytotoxic T lymphocytes during asymptomatic HIV infection

X. Jin, M. Wills, J. Sissons, 1998, European journal of immunology.